Siro ClinPharm and ACT team up on oncology

By Gareth Macdonald

- Last updated on GMT

Indian CRO Siro ClinPharm is teaming up with New Jersey based pharma services firm Advanced Clinical Trial Solutions (ACT) to strengthen its position in the US cancer trial sector.

The partnership, financial terms of which have not been released, will add ACT’s clinical development and patient recruitment offerings for oncology drug trials to Siro’s existing portfolio of services.

In return, ACT’s US customer base will have access to Siro’s extensive network of Indian and European data management, patient recruitment, biostatistics and distribution services.

Siro’s US president, Patricia Terek, reiterated the projects’ core focus, explaining that the deal “will help meet the growing needs of our oncology customers to have access to operational capabilities in North America.”

Siro, which is India’s largest integrated clinical trials organisation, entered the US market in July 2007 through its acquisition of contract research organisation (CRO) Global Client Partners.

The firm also has operations in Germany, Greece, Estonia and Israel, that it bought as part of its takeover of Offenbach-based firm Omega Mediation in 2008.

Siro to Invest in India?

While the ACT partnership clearly shows the value Siro places on the US market, recent comments by shareholder 3i India suggest that the Mumbai group plans to further strengthen its position in its home territory.

3i India’s Mahesh Chhabria told Livemint​ that: “ We are currently looking at several proposals for comparatively large investments in the country’s pharmaceuticals, medical devices manufacturing, and health care and laboratory services industries, including large and medium hospital groups​.”

Chhabria explained that two of the options under consideration are acquisitions by Siro in India, but said that no move would be made until the integration of Omega is completed later this year.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars